Sona Nanotech Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SNANF research report →
Price Chart
About the company
Sona Nanotech Inc. is a life sciences enterprise specializing in nanotechnology, primarily engaged in the development and commercialization of gold nanorod products for diagnostic purposes. The company's offerings also encompass distinct gold nanorod varieties, such as Gemini and Omni (the latter tailored specifically for medical uses), alongside providing specialized contract services.
- CEO
- David Andrew Regan
- IPO
- 2006
- Employees
- 8
- HQ
- Halifax, NS, CA
Get TickerSpark's AI analysis on SNANF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $25.28M
- P/E
- -14.72
- PEG
- -0.49
- P/S
- 0.00
- P/B
- -28.54
- EV/EBITDA
- -19.16
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 448.05%
- ROIC
- 273.52%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $-719,903+0.0%
- Op Income
- $-3,441,821
- Net Income
- $-3,249,908-20.2%
- EPS
- $-0.03-7.4%
- OCF Growth
- -0.1%
- FCF Growth
- -0.1%
- 52W High
- $0.59
- 52W Low
- $0.19
- 50D MA
- $0.24
- 200D MA
- $0.26
- Beta
- 0.98
- RSI (14)
- 27
- Avg Volume
- 5.39K
No earnings-call transcripts are available for SNANF yet.
- Free Float
- 84.5%
- Shares Outstanding
- 114.38M
- Float Shares
- 96.63M
Our SNANF coverage
Recent articles, reports, and earnings notes.
No research on SNANF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SNANF report →Sona Nanotech to Present at the OTC Markets' Life Sciences Virtual Investor Forum On September 17th
globenewswire.com · Sep 11
Dow rockets higher as Strait of Hormuz stays open, talks eyed
proactiveinvestors.com · Apr 17
Iran's blockade of the Strait of Hormuz has wiped out a third of global helium supply, and the scramble for secure alternatives has begun
proactiveinvestors.com · Apr 17
Dow powers higher as oil slump, easing tensions lift stocks
proactiveinvestors.com · Apr 17
Hims & Hers shares jump as FDA begins review of restricted peptide compounds
proactiveinvestors.com · Apr 16
Sona Nanotech appoints two oncologists to scientific advisory board
proactiveinvestors.com · Apr 16
Sona Nanotech appoints two oncologists to scientific advisory board
proactiveinvestors.com · Apr 16
Sona Nanotech reports immune activation in melanoma trial of heat-based therapy
proactiveinvestors.com · Apr 13
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.